Each month, the Geographic Health Equity Alliance (GHEA) aggregates the latest news and research related to place-based cancer control and geographic health disparities. Below you will find the latest posts, updated regularly throughout the month.
(Last Updated: May 20, 2021)
General Cancer Control News and Research
- A study on self-reported HPV vaccination rates among young adult participants found that 46.3 percent of women received their three-dose vaccination series compared to 29.1 percent of men.
- Lisa Newman, Chief of Breast Surgery at the New York-Presbyterian and Weill Cornell Medicine, discusses how new ideas and innovations are changing advanced breast cancer.
- According to a recent study, people of color, those with higher incomes and younger individuals are more likely to participate in clinical trials during their cancer treatment.
- The American Cancer Society updated its Common Questions About the COVID-19 Outbreak which helps cancer patients, their caregivers and others learn about precautions to lower their risk of getting COVID-19.
- New data suggests that two treatment procedures for patients with breast cancer remain common in older patients, even though they do not appear to have a significant impact on health outcomes.
- The Global Breast Cancer Initiative highlights renewed commitment to improving survival rates. This new initiative is a collaborative effort by the World Health Organization, International Agency for Research on Cancer and International Atomic Energy Agency.
- CDC’s Comprehensive Control National Partnership has added a new Health Equity Tip Sheet to their series. These tip sheets are designed to help Comprehensive Cancer Control program staff, coalition staff and volunteers update their cancer plans.
- A new study found that women who had a high consumption of sugar-sweetened drinks in adolescence and young adulthood had a twofold increase in the risk of colorectal cancer before the age of 50.
- Researchers find that in the United States, nearly 10 million cancer screenings have been missed during the coronavirus pandemic. Screening data on breast, colon and prostate cancer were examined. Researchers conclude that public health efforts are needed to address the large cancer screening deficit associated with the COVID-19 pandemic.
- A study finds that more patients with estrogen receptor-positive, HER2-negative breast cancer have been treated with neoadjuvant endocrine therapy due to COVID-19.
- A national survey on patient factors and colorectal cancer screening preferences found that over 60 percent of patients preferred stool-based screening tests over colonoscopies.
- A research study finds that in comparison with the general population, breast cancer survivors have a higher risk of new cancer diagnoses. The risk of new cancer diagnoses among survivors was 20 percent higher for those with hormone receptor positive cancers and 44 percent higher for those with HR-negative cancers.
